Keeping current with the retina literature is, for most, an ongoing, futile effort. New journals are constantly being introduced, and existing journals keep getting thicker and thicker. Researching a topic on PubMed doesn’t allow you to spot key references or quickly digest what’s new globally on a topic of interest. And remembering what you’ve read a few weeks later (or even after you’ve turned the page to the next article) is a struggle.
To address these concerns, we pull key clinical references from 24 major ophthalmic and retinal journals each month (click here for the journal list). Although we can’t provide the journal article PDF due to copyright issues, we provide a single-line citation with a brief summary of the article’s main points. Our goal is to capture all major clinically relevant references.
Please contact us if we’re missing any key references or if any reference is mis-summarized or cited.
That’s easy! Just subscribe to the Retina World Congress’s monthly email blast here.
At the top of most Image Library folders is a ___References Word document containing the annotated bibliography for that topic. Every month, we file key articles into the appropriate Retina Rocks folder(s) and update this file. Key articles are located at the top of the list. This allows for a rapid snapshot and review of the literature while also looking through our multimedia images. Some seemingly unrelated references are included in each folder to aid in differential diagnosis or to learn about similar findings in other disorders.
Here is the current month's snapshot of key retina journal articles
Retina. 2026 Jul 1;46(7):1272-1281. doi: 10.1097/IAE.0000000000004811.
ICSC with baseline perifoveal FFA leak: Longer symptom duration, complex disease, and irregular outer segment thickening associated with increased EZ atrophy at resolution — Micron Retrospective, 84 eyes.
Graefes Arch Clin Exp Ophthalmol. 2026 Jul;264(7):2105-2118. doi: 10.1007/s00417-025-07058-3.
Systematic review and meta-analysis of AMD confirms association with CFH Y402H and ARMS A69S polymorphisms.
Retina. 2026 Jul 1;46(7):1160-1169. doi: 10.1097/IAE.0000000000004827.
RPE tumors: Large clinical series including CHRPE (most common), torpedo, RPE hamartoma, combined hamartoma, adenoma, and adenocarcinoma — Retrospective, 926 patients.
Ophthalmol Retina. 2026 Jul;10(7):691-699. doi: 10.1016/j.oret.2026.03.014.
Primary RRD PPV vs PPV+ lensectomy: Similar anatomic success. Multicenter propensity-matched study, 6113 eyes.
Ophthalmologica. 2026;249(3):238-248. doi: 10.1159/000551308.
Non-exudative AMD: MNV Found in 7% of fellow nAMD eyes receiving anti-VEGF. Increased lesion growth rate associated with conversion to future exudation — Retrospective, 61 eyes.
Graefes Arch Clin Exp Ophthalmol. 2026 Jul;264(7):1949-1961. doi: 10.1007/s00417-026-07188-2.
Glaucoma attenuates but doesn’t eliminate the visual benefits of PPV for macular pucker. Central VF may be compromised in moderate to advanced disease — Meta-analysis.
JAMA Ophthalmol. 2026 Jul 1;144(7):659-661. doi: 10.1001/jamaophthalmol.2026.1610.
Case of bilateral occlusive retinal vasculitis after Vabysmo rechallenge.
Ophthalmol Retina. 2026 Jul;10(7):745-752. doi: 10.1016/j.oret.2026.03.007.
Diabetic retinal disease does not progress faster in those 25YO or younger. Those 65 YO and older showed a decline in DRD prevalence and incidence over the observation period. Retrospective, Medicare database.
Ophthalmol Retina. 2026 Jul;10(7):707-718. doi: 10.1016/j.oret.2026.02.020.
PULSAR post hoc nAMD: Eylea HD Similar functional and anatomic results as Eylea 2mg, but with longer dosing intervals, regardless of baseline severity.
Retina. 2026 Jul 1;46(7):1170-1177. doi: 10.1097/IAE.0000000000004806.
Prior contralateral RRD/RB increases risk of break-RD in fellow eye with lattice. Increased odds ratio 4.47. Myopia increased risk — Retrospective, TriNetX.
Retin Cases Brief Rep. 2026 Jul 1;20(4):510-514. doi: 10.1097/ICB.0000000000001772.
IMPG1-associated vitelliform dystrophy: Brother and sister with different phenotypes, including foveal and multifocal lesions.
Retina. 2026 Jul 1;46(7):1231-1240. doi: 10.1097/IAE.0000000000004813.
Initiation of Vabysmo or Eylea HD extended Tx intervals, and better VA vs eyes switched from older agents. Suggests step therapy may compromise outcomes. Retrospective real-world — 12501 eyes. With Spaide editorial.
Ophthalmology. 2026 Jul;133(7):837-851. doi: 10.1016/j.ophtha.2026.03.019.
Iluvien vs Eylea as primary DME treatment. Iluvien fewer than half total injections with similar VA and anatomic outcomes. 28% in Iluvien group underwent cataract surgery vs 7% in Eylea group. 4 NEW DAY, Prospective, 18-month RCT — 517 patients.
Clin Exp Ophthalmol. 2026 May-Jun;54(4):507-513. doi: 10.1111/ceo.70058.
Post-Vabysmo IOI: Developed on average after 5 injections, all uveitis with anterior vitritis, most 2-7 weeks post-injection with high IOP — Retrospective, 8 eyes.
Ophthalmol Retina. 2026 Jul;10(7):774-776. doi: 10.1016/j.oret.2025.11.011.
High-stakes errors: Incorrect gas mixtures in vitreoretinal surgery. Settled OMIC malpractice cases from incorrect gas concentration or volume. With editorial.
Clin Exp Ophthalmol. 2026 May-Jun;54(4):554-564. doi: 10.1111/ceo.70096.
Link between GLP1 agonists and NAION. Current meta-analyses suggest 2-3 times increased risk — Review
Retina. 2026 Jul 1;46(7):1220-1228. doi: 10.1097/IAE.0000000000004819.
Eylea HD vs Vabysmo for Tx-naive nAMD: After 3 loading doses, comparable anatomic and functional outcomes. Retrospective —100 eyes.
Am J Ophthalmol. 2026 Jul:287:285-297. doi: 10.1016/j.ajo.2026.03.040.
Vitreous opacities psychological burden and interventional outcomes: Higher levels of depression, anxiety, and perceived stress. VA underestimates functional impairment — Systematic Review.
Am J Ophthalmol. 2026 Jul:287:198-207. doi: 10.1016/j.ajo.2026.03.031.
Diabetic macular OCTA DCP perfusion defects biomarker for ischemia in all retinal regions on UWF FA. Increased FAZ reflected posterior ischemia. Prospective — 159 eyes.
Eye (Lond). 2026 Jul;40(10):1461-1468. doi: 10.1038/s41433-026-04462-9.
Visual field screening for chloroquine-hydroxychloroquine toxicity: 24-2 and 24-2C similar efficacy but 24-2C minimized testing time. Prospective — 75 patients.
Ophthalmol Retina. 2026 Jul;10(7):764-773. doi: 10.1016/j.oret.2026.03.013.
Acute ischemic ocular events (RAO, amaurosis) increased risk for ischemic stroke-TIA, especially within 30 days. EMR database.
Receive Retina Rocks content in the RWC monthly newsletter!
Retina Rocks is the image bank of the Retina World Congress.